Key Insights

Highlights

Success Rate

100% trial completion (above average)

Published Results

12 trials with published results (44%)

Clinical Risk Assessment

Based on trial outcomes

Low Risk

Score: 17/100

Termination Rate

0.0%

0 terminated out of 27 trials

Success Rate

100.0%

+13.5% vs benchmark

Late-Stage Pipeline

52%

14 trials in Phase 3/4

Results Transparency

50%

12 of 24 completed with results

Key Signals

12 with results100% success

Data Visualizations

Phase Distribution

24Total
Not Applicable (3)
P 1 (2)
P 2 (5)
P 3 (10)
P 4 (4)

Trial Status

Completed24
Unknown2
Not Yet Recruiting1

Trial Success Rate

100.0%

Benchmark: 86.5%

Based on 24 completed trials

Clinical Trials (27)

Showing 20 of 20 trials
NCT06771648Not ApplicableCompletedPrimary

Daxxin Psoriasis Shampoo PMCF

NCT05969223Phase 4Completed

Study to Assess the Safety and Efficacy of Subcutaneously Injected Risankizumab in Adult Participants With Genital or Scalp Psoriasis

NCT05272150Phase 3Completed

Study of Guselkumab in Skin of Color Participants With Moderate-to-severe Plaque and/or Scalp Psoriasis

NCT05028582Phase 3CompletedPrimary

Topical Roflumilast to Treat Scalp and Body Psoriasis (ARRECTOR)

NCT01195831Phase 3CompletedPrimary

Efficacy and Safety of Xamiol® Gel Compared to Calcipotriol Scalp Solution in Patients With Scalp Psoriasis

NCT01083758Phase 2CompletedPrimary

Safety and Efficacy of LEO 80185 Topical Suspension in Adolescent Subjects (Aged 12 to 17) With Scalp Psoriasis

NCT01120223Phase 2CompletedPrimary

Safety and Efficacy of LEO 80185 Gel in Adolescent Subjects (Aged 12 to 17) With Scalp Psoriasis

NCT01052467CompletedPrimary

Topical Treatment of Scalp Psoriasis With the Fixed Combination of Calcipotriol and Betamethason (Xamiol® Gel)

NCT06802848Not Yet Recruiting

Real-World Study of Xeligekimab for Moderate to Severe Plaque Psoriasis(XP-Real)

NCT05872256Phase 4CompletedPrimary

A Demonstration of the Hair and Scalp Benefits of Duobrii in Scalp Psoriasis

NCT06015152Not ApplicableCompletedPrimary

Comparison Of Efficacy Of Tazarotene 0.045% Vs Halobetasol Propionate 0.01% Lotion For Treatment of Scalp Psoriasis

NCT00400725Phase 3CompletedPrimary

Maintenance Effect of Clobex Shampoo on Participants With Moderate to Severe Scalp Psoriasis

NCT03897088Phase 3CompletedPrimary

Efficacy and Safety of Tildrakizumab in the Treatment of Scalp Psoriasis

NCT00881868Phase 4CompletedPrimary

Clobetasol Propionate Spray Versus Vehicle Spray for the Management of Moderate to Severe Plaque Psoriasis of the Scalp

NCT04801433Not ApplicableCompletedPrimary

Evaluate the Efficacy and Safety of Boroda Supramolecular Active Zinc in the Treatment of Scalp Psoriasis

NCT00438399Phase 3CompletedPrimary

Subject Preference for Scalp Psoriasis Treatment

NCT04243486Phase 2CompletedPrimary

A Study of the Safety and Efficacy of UHE-105 Shampoo in Subjects With Scalp Psoriasis

NCT03880357Phase 1CompletedPrimary

To Evaluate the Therapeutic Equivalence and Safety in Treatment of Scalp Psoriasis

NCT03331523Phase 3CompletedPrimary

To Study Generic Calcipotriene and Betamethasone Dipropionate Topical Suspension, 0.005%/0.064%, in the Treatment of Scalp Psoriasis

NCT02933502Phase 2CompletedPrimary

Safety Study in Patients With Scalp Psoriasis Suppression Following Maximal Use Treatment With Topical Product

Scroll to load more

Research Network

Activity Timeline